ConductScience.org, home

Paper42886331PubMed

Subtype-Specific Efficacy of Adrenoceptor Agonists in Inhibiting Lens-Induced Myopia in Chicks.

Uddin M and 6 others. Ophthalmic Physiol Opt, 2026.

Cite this record

ConductScience Library. Subtype-Specific Efficacy of Adrenoceptor Agonists in Inhibiting Lens-Induced Myopia in Chicks. Papers, record 42886331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42886331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Subtype-Specific Efficacy of Adrenoceptor Agonists in Inhibiting Lens-Induced Myopia in Chicks.
Journal
Ophthalmic Physiol Opt
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-16

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uddin MMezbah
2Yu FFengjuan
3Chun RKMRachel Ka Manhttps://orcid.org/0000-0001-6978-0963
4Zuo BBing
5Li KKKing Kit
6To CHChi Ho
7Tse DYDennis Yan-Yin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126875007Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050.Ophthalmology2016https://conductscience.org/library/papers/26875007PubMed
28949710Risk of retinal detachment following cataract extraction: results from the International Cataract Surgery Outcomes Study.Br J Ophthalmol1996https://conductscience.org/library/papers/8949710PubMed
318812113Retinal detachment after phacoemulsification in high myopia: analysis of 2356 cases.J Cataract Refract Surg2008https://conductscience.org/library/papers/18812113PubMed
423499368Myopia-related fundus changes in Singapore adults with high myopia.Am J Ophthalmol2013https://conductscience.org/library/papers/23499368PubMed
521596297An evidence-based update on myopia and interventions to retard its progression.J AAPOS2011https://conductscience.org/library/papers/21596297PubMed
626271839Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.Ophthalmology2016https://conductscience.org/library/papers/26271839PubMed
730514630Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.Ophthalmology2019https://conductscience.org/library/papers/30514630PubMed
829715053A Review of Myopia Control with Atropine.J Ocul Pharmacol Ther2018https://conductscience.org/library/papers/29715053PubMed
921258611Pharmaceutical intervention for myopia control.Expert Rev Ophthalmol2010https://conductscience.org/library/papers/21258611PubMed
1028494063Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.JAMA Ophthalmol2017https://conductscience.org/library/papers/28494063PubMed
11401225783-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial.Br J Ophthalmol2025https://conductscience.org/library/papers/40122578PubMed
1238318144Myopia progression after cessation of atropine in children: a systematic review and meta-analysis.Front Pharmacol2024https://conductscience.org/library/papers/38318144PubMed
1321539592The M4 muscarinic antagonist MT-3 inhibits myopia in chick: evidence for site of action.Ophthalmic Physiol Opt2011https://conductscience.org/library/papers/21539592PubMed
1429860464Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.Invest Ophthalmol Vis Sci2018https://conductscience.org/library/papers/29860464PubMed
158425826Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism.Invest Ophthalmol Vis Sci1993https://conductscience.org/library/papers/8425826PubMed
1621557730Adrenoceptor activity of muscarinic toxins identified from mamba venoms.Br J Pharmacol2011https://conductscience.org/library/papers/21557730PubMed
1730699466Alpha2 -adrenoceptor agonists inhibit form-deprivation myopia in the chick.Clin Exp Optom2019https://conductscience.org/library/papers/30699466PubMed
1838605375Brimonidine as a possible treatment for myopia.BMC Ophthalmol2024https://conductscience.org/library/papers/38605375PubMed
1939309849The potential of brimonidine for myopia treatment: Targeting MMP-2 to regulate choroidal thickness and control eye growth.Heliyon2024https://conductscience.org/library/papers/39309849PubMed
2037955611Topical Application of Bunazosin Hydrochloride Suppresses Myopia Progression With an Increase in Choroidal Blood Perfusion.Invest Ophthalmol Vis Sci2023https://conductscience.org/library/papers/37955611PubMed

See all 57 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42886331

GET https://conductscience.org/api/papers/v1/42886331/references?page=2